Abstract
The highly structured mechanisms of cancers, their tendency to occur as a response to environmental stress, and the existence of oncogenes, suggest that neoplasticity may represent more than a biological disfunction. It is proposed that cancer exists as a phylogenetic mechanism serving to promote “hyperevolution”, albeit at the expense of the ontogeny, that is similar to a process recently discovered in bacterial mutations. Cell-surface-associated nucleic acid in tumorigenic cells and sperm cell vectorization of foreign DNA indicate the existence of essential mechanisms necessary to the occurrence of cancer mediated hyperevolution. An analysis of the proposed mechanism indicates that for mutagenesis of chemical cytology, stress induced neoplasticity confers an evolutionary advantage of more than two orders of magnitude.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aggarwal, S.K., R.W. Wagner, P.K. McAllister and B. Rosenberg (1975). Cell-surface-associated nucleic acid in tumorigenic cells made visible with platinum-pyrimidine complexes by electron microscopy. Proceedings of the National Academy of Sciences USA 72: 928–932.
Bennett, R.M., G.T. Gabor and M.M. Merritt (1985). DNA binding to human leukocytes. Journal of Clinical Investigation 76: 2181–2190.
Bennett, R.M., S.H. Hefeneider, A. Bakke, M.M. Merritt, C.A. Smith, D. Mourich and M.C. Heinrich (1988). The production and characterization of murine monoclonal antibodies to a DNA receptor on human leukocytes. Journal of Immunology 140: 2937–2942.
Berridge, M.V., J.C. Nargang, P.T. Loverde and E.S. Golub (1980). The culture of mouse thymic reticulum cells: The effect of homologous serum on the establishment of primary cultures. Journal of Immunology 124: 2738–2746.
Brand, K.G. (1975). Foreign body induced sarcomas. In: F.F. Becker, ed., Cancer 1, 485–511. New York: Plenum Press.
Brinster, R.L., E.P. Sandgrer, R.R. Behringer and R.D. Palmiter (1989). No simple solution for making transgenic mice. Cell 59: 239–241.
Cairns, J., I. Overbaugh and S. Miller (1988). The origin of mutants. Nature 335: 142–145.
Cairns, J. (1989). The evolution of cancer research. Cancer Cells 1: 1–8.
Darwin, C. (1958). The Origin of Species. New York: New American Library.
Doll, R. (1977). Introduction. In: H.H. Hiatt, J.D. Watson & J.A. Winsten, eds. Origins of Human Cancer, 1–12. Cold Spring Harbor Laboratory.
Eldredge, N. and S.J. Gould (1972). Punctuated equilibria: An alternative to phyletic gradualism. In: T.J.M. Schopf, ed. Models in Paleobiology, 82–115. San Francisco: Freeman, Cooper and Co.
Emlen, W., A. Rifai, D. Magilavy and M. Mannik (1988). Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells. American Journal of Pathology 133: 54–60.
Foulds, L. (1954). The experimental study of tumor progression: A review. Cancer Research 14: 317–339.
Goldberg, S. and V. Defendi (1979). Increased mutation rates in doubly viral transformed Chinese hamster cells. Somat. Cell Genet. 5: 887–895.
Hall, B.G. (1988). Adaptive evolution that requires multiple spontaneous mutations. Genetics 120: 887–897.
Hollinshead, A.C. (1979). Proceedings of the American Association for Cancer Research.
Hollstein, M., D. Sidransky, B. Vogelstein and C.C. Harris (1991). p53 mutations in human cancers. Science 253: 49–53.
Juckett, D.A. and B. Rosenberg (1982). Actions of cis-diamminedichloroplatinum on cell surface nucleic acids in cancer cells as determined by cell electrophoresis techniques. Cancer Research 42: 3565–3573.
Kaden, D.A., L. Bardwell, P. Newmark, A. Anisowicz, T.R. Skopek and R. Sager (1989). High frequency of large spontaneous deletions of DNA in tumor-derived CHEF cells. Proc. Natl. Acad. Sci. USA 86: 2306–2310.
Lavitrano, M., A. Camaioni, V.M. Fazio, S. Dolci, M.G. Farace and C. Spadafora (1989). Sperm cells as vectors for introducing foreign DNA into eggs: Genetic transformation of mice. Cell 57: 717–723.
Lerner, R.A., W. Meinke and D.A. Goldstein (1971). Membrane-associated DNA in the cytoplasm of diploid human lymphocytes. Proceedings of the National Academy of Sciences USA 68: 1212–1216.
Lewin, R. (1988). A heresy in evolutionary biology. Science 241: 1431.
Loeb, L.A. (in press). A mutator phenotype may be required for multi-stage carcinogenesis. Cancer Research.
Murphy, W.J., V. Kumar and M. Bennett (1987). Rejection of bone marrow allographs by mice with severe combined immune deficiency (SCID). Journal of Experimental Medicine 165: 1212–1217.
Russell, J. and E.S. Golub (1978). Leukemia in AKR mice: A defined suppressorcell population expressing membrane-associated DNA. Proceedings of the National Academy of Sciences USA 75: 6211–6214.
Seshadri, R., R.I. Kutlaca, K. Trainor, C. Matthews and A.A. Morley (1987). Mutation rate of normal and malignant human lymphocytes. Cancer Research 47: 407–409.
Temin, H.M. (1971). The protovirus hypothesis: Speculations on the significance of RNA-directed DNA synthesis for normal development and for carcinogenesis. Journal of the National Cancer Institute 46: iii-vii.
Weismann, A. (1983). The Germ-Plasm: A Theory of Heredity. Translated by W.N. Parker and H. Römmfeldt. London: Walter Scott Ltd.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walker, E.H. Cancer as a mechanism of hypermutation. Acta Biotheor 40, 31–40 (1992). https://doi.org/10.1007/BF00046549
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00046549